Cart
sales@molnova.com
Londamocitinib
CAS No. 2241039-81-4
Londamocitinib( —— )
Catalog No. M32971 CAS No. 2241039-81-4
Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 287 | Get Quote |
|
| 5MG | 440 | Get Quote |
|
| 10MG | 598 | Get Quote |
|
| 25MG | 877 | Get Quote |
|
| 50MG | 1132 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLondamocitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLondamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
-
DescriptionLondamocitinib (AZD4604; JAK1-IN-7) is a Janus-associated kinase 1 (JAK1) inhibitor extracted from patent WO2018134213A1, Example 63, has an anti-inflammatory effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2241039-81-4
-
Formula Weight599.65
-
Molecular FormulaC28H31F2N7O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 71.43 mg/mL (119.12 mM; Ultrasonic )
-
SMILESCOC[C@@H](N1CCN(C)CC1)C(=O)Nc1cccc2c(c[nH]c12)-c1nc(Nc2cccc(c2F)S(C)(=O)=O)ncc1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. NILSSON, Karl, Magnus, et al. Jak1 selective inhibitors. WO2018134213A1.
molnova catalog
related products
-
Ruxolitinib sulfate
A potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively.
-
Sweroside
Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.
-
JAK3i
JAK3i is a selective, covalent JAK3 kinase inhibitor with IC50 of 0.43 nM.
